[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100639052":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":29,"centralContacts":35,"locations":41,"responsibleParty":142,"collaborators":29,"id":144,"slug":145,"hasResults":146,"nctId":147,"briefTitle":148,"officialTitle":149,"acronym":29,"eligibilityCriteria":150,"healthyVolunteers":146,"sex":151,"minAge":152,"maxAge":29,"enrollmentInfo":153,"targetDuration":29,"studyType":156,"phases":157,"briefSummary":159,"conditions":160,"keywords":29,"overallStatus":162,"whyStopped":29,"lastUpdateSubmitDate":163,"lastUpdatePostDateStruct":164,"startDateStruct":167,"completionDateStruct":169,"leadSponsor":171,"locationsCount":172},{"fullName":5,"class":6},"ScinnoHub Pharmaceutical Co., Ltd.","INDUSTRY",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Cohort 1","EXPERIMENTAL","Study Drug",[13],"Drug: SNH-119014 dose 1",{"label":15,"type":10,"description":11,"interventionNames":16},"Cohort 2",[17],"Drug: SNH-119014 dose 2",{"label":19,"type":20,"description":21,"interventionNames":22},"Cohort 3","PLACEBO_COMPARATOR","Placebo",[23],"Drug: Placebo",[25,30,33],{"type":26,"name":27,"description":11,"armGroupLabels":28,"otherNames":29},"DRUG","SNH-119014 dose 1",[9],null,{"type":26,"name":31,"description":11,"armGroupLabels":32,"otherNames":29},"SNH-119014 dose 2",[15],{"type":26,"name":21,"description":21,"armGroupLabels":34,"otherNames":29},[19],[36],{"name":37,"role":38,"phone":39,"phoneExt":29,"email":40},"Yongrong Lai, Ph.D","CONTACT","0771-6356510","laiyongrong@263.net",[42,59,72,85,99,112,119,128],{"facility":43,"status":29,"city":44,"state":45,"zip":29,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Foshan First People's Hospital","Foshan","Guangdong","China","CN",{"type":49,"coordinates":50},"Point",[51,52],113.13148,23.02677,{"lat":52,"lon":51},[55],{"name":56,"role":38,"phone":57,"phoneExt":29,"email":58},"Yonglei Qi","18038865128","qylei12@fsyyy.com",{"facility":60,"status":29,"city":61,"state":45,"zip":29,"country":46,"countryCode":47,"cosmosGeoPoint":62,"geoPoint":66,"contacts":67},"Nanfang Hospital, Southern Medical University","Guangzhou",{"type":49,"coordinates":63},[64,65],113.25,23.11667,{"lat":65,"lon":64},[68],{"name":69,"role":38,"phone":70,"phoneExt":29,"email":71},"Ling Jiang","18620109403","jlapple@126.com",{"facility":73,"status":29,"city":74,"state":45,"zip":29,"country":46,"countryCode":47,"cosmosGeoPoint":75,"geoPoint":79,"contacts":80},"Maoming People's Hospital","Maoming",{"type":49,"coordinates":76},[77,78],110.91364,21.66625,{"lat":78,"lon":77},[81],{"name":82,"role":38,"phone":83,"phoneExt":29,"email":84},"Ying Dong","13432321706","997281241@qq.com",{"facility":86,"status":29,"city":87,"state":88,"zip":29,"country":46,"countryCode":47,"cosmosGeoPoint":89,"geoPoint":93,"contacts":94},"Liuzhou People's Hospital","Liuzhou","Guangxi",{"type":49,"coordinates":90},[91,92],109.40698,24.32405,{"lat":92,"lon":91},[95],{"name":96,"role":38,"phone":97,"phoneExt":29,"email":98},"Liuting Lu","13558224507","289761556@qq.com",{"facility":100,"status":29,"city":101,"state":88,"zip":29,"country":46,"countryCode":47,"cosmosGeoPoint":102,"geoPoint":106,"contacts":107},"923rd Hospital of the Joint Logistics Support Force of the People's Liberation Army of China","Nanning",{"type":49,"coordinates":103},[104,105],108.31667,22.81667,{"lat":105,"lon":104},[108],{"name":109,"role":38,"phone":110,"phoneExt":29,"email":111},"Yali Zhou","13507883961","252749070@qq.com",{"facility":113,"status":29,"city":101,"state":88,"zip":29,"country":46,"countryCode":47,"cosmosGeoPoint":114,"geoPoint":116,"contacts":117},"The First Affiliated Hospital of Guangxi Medical University",{"type":49,"coordinates":115},[104,105],{"lat":105,"lon":104},[118],{"name":37,"role":38,"phone":39,"phoneExt":29,"email":40},{"facility":120,"status":29,"city":121,"state":122,"zip":29,"country":46,"countryCode":47,"cosmosGeoPoint":29,"geoPoint":29,"contacts":123},"The First Affiliated Hospital of Hainan Medical University","Haikou","Hunan",[124],{"name":125,"role":38,"phone":126,"phoneExt":29,"email":127},"Lu Xu","13518073033","xulu2324@163.com",{"facility":129,"status":29,"city":130,"state":131,"zip":29,"country":46,"countryCode":47,"cosmosGeoPoint":132,"geoPoint":136,"contacts":137},"Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital","Chengdu","Sichuan",{"type":49,"coordinates":133},[134,135],104.06667,30.66667,{"lat":135,"lon":134},[138],{"name":139,"role":38,"phone":140,"phoneExt":29,"email":141},"Xiaobing Huang","18981838236","huangxiaobing@med.uestc.edu.cn",{"type":143,"investigatorFullName":29,"investigatorTitle":29,"investigatorAffiliation":29,"oldNameTitle":29,"oldOrganization":29},"SPONSOR","100639052","phase-2-a-study-of-snh-119014-in-adult-participants-with-non-transfusion-dependent-thalassemia-ntdt-100639052",false,"NCT07579949","A Study of SNH-119014 in Adult Participants With Non-transfusion-dependent Thalassemia (NTDT)","A Phase 2 Study to Determine the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SNH-119014 in Adult Subjects With Non-transfusion-dependent Thalassemia","Inclusion Criteria:\n\n* Male or Female;\n\n  -≥18 years;\n* Documented diagnosis of thalassemia;\n* Non-transfusion-dependent;\n* Hb concentration ≤10.0 grams per deciliter (g\u002FdL) during the screening period;\n* For women of reproductive potential: negative serum pregnancy test during the screening period;\n* Agreement to use approved contraceptive measures;\n* Informed consent;\n\nExclusion Criteria:\n\n* Hemoglobin S forms of thalassemia;\n* History of Congestive Heart Failure Within 6 months prior to signed informed consent;\n* Myocardial Infarction\u002Funstable angina Within 6 months prior to signed informed consent;\n* Deep Vein Thrombosis\u002Fstroke\u002Fthromboembolic events Within 6 months prior to signed informed consent;\n* Poorly controlled hypertension or diabetes;\n* Markedly abnormal QTcF interval;\n* Severe arrhythmia requiring treatment as assessed by the investigator;\n* Markedly abnormal left ventricular ejection fraction;\n* Diagnosis of any other congenital or acquired hematologic disorder, or any other hemolytic process;\n* Active infection requiring intravenous antibiotics or of Grade ≥3 severity within 4 weeks prior to the first dose;\n* History of primary malignancy, except for: cured non-melanoma skin cancer; curatively treated cervical or breast carcinoma in situ; or other primary tumors treated with curative intent with no known active disease and no treatment in the past 5 years;\n* History of neurological or psychiatric disorders that, in the investigator's assessment, may affect the participant's ability to participate in the clinical study;\n* Post-splenectomy sepsis;\n* Severe pulmonary disease or hepatobiliary disease;\n* Abnormal laboratory tests during screening;\n* Use of luspatercept, hydroxyurea, erythropoietin, strong CYP3A4 inhibitors, or strong CYP3A4 inducers within the prohibited period specified in the protocol;\n* Receipt of anticoagulant therapy prior to screening, or requirement for anticoagulant therapy during the study period;\n* Prior bone marrow or stem cell transplant;\n* Pregnant or lactating women;\n* Major surgery within 6 months prior to signing informed consent or planned during the study period;\n* Splenectomy scheduled during the study treatment period;\n* Participation in another clinical trial and receipt of investigational treatment within 3 months;\n* History of severe allergy, or allergy to SNH-119014 or its excipients;\n* Any other condition that, in the investigator's opinion, makes the participant unsuitable for enrollment.","ALL","18 Years",{"count":154,"type":155},30,"ESTIMATED","INTERVENTIONAL",[158],"PHASE2","This study is a multicenter study to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of treatment with SNH-119014 in adult participants with non-transfusion-dependent thalassemia. 30 participants with non-transfusion-dependent thalassemia were enrolled.",[161],"Thalassemia","NOT_YET_RECRUITING","2026-05-06",{"date":165,"type":166},"2026-05-12","ACTUAL",{"date":168,"type":155},"2026-06-18",{"date":170,"type":155},"2027-04-29",{"name":5,"class":6},8]